[go: up one dir, main page]

WO2000077236A3 - Methods for enhancing the production of cytokines in cell cultur e - Google Patents

Methods for enhancing the production of cytokines in cell cultur e Download PDF

Info

Publication number
WO2000077236A3
WO2000077236A3 PCT/US2000/040199 US0040199W WO0077236A3 WO 2000077236 A3 WO2000077236 A3 WO 2000077236A3 US 0040199 W US0040199 W US 0040199W WO 0077236 A3 WO0077236 A3 WO 0077236A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
cytokines
enhancing
methods
cytokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/040199
Other languages
French (fr)
Other versions
WO2000077236A2 (en
Inventor
Allan S Lau
Laura Browning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetrol Biotherapeutics Inc
Original Assignee
Genetrol Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetrol Biotherapeutics Inc filed Critical Genetrol Biotherapeutics Inc
Priority to EP00951042A priority Critical patent/EP1255848A2/en
Priority to CA002376487A priority patent/CA2376487A1/en
Priority to JP2001503677A priority patent/JP2003509012A/en
Priority to HK03100710.6A priority patent/HK1048650A1/en
Priority to AU64037/00A priority patent/AU6403700A/en
Publication of WO2000077236A2 publication Critical patent/WO2000077236A2/en
Anticipated expiration legal-status Critical
Publication of WO2000077236A3 publication Critical patent/WO2000077236A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is directed to methods for enhancing the production of cytokines in mammalian cell culture by modifying the level of a cytokine regulatory factor in the cells, resulting in enhanced levels of cytokine production. The invention is further directed to cell lines which exhibit enhanced cytokine regulatory factor expression and enhanced cytokine expression.
PCT/US2000/040199 1999-06-15 2000-06-14 Methods for enhancing the production of cytokines in cell cultur e Ceased WO2000077236A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP00951042A EP1255848A2 (en) 1999-06-15 2000-06-14 Methods for enhancing the production of cytokines in cell cultur e
CA002376487A CA2376487A1 (en) 1999-06-15 2000-06-14 Methods for enhancing the production of cytokines in cell culture
JP2001503677A JP2003509012A (en) 1999-06-15 2000-06-14 Methods for enhancing cytokine production in cell culture
HK03100710.6A HK1048650A1 (en) 1999-06-15 2000-06-14 Methods for enhancing the production of cytokines in cell cultur e
AU64037/00A AU6403700A (en) 1999-06-15 2000-06-14 Methods for enhancing the production of cytokines in cell culture

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13931399P 1999-06-15 1999-06-15
US60/139,313 1999-06-15

Publications (2)

Publication Number Publication Date
WO2000077236A2 WO2000077236A2 (en) 2000-12-21
WO2000077236A3 true WO2000077236A3 (en) 2002-09-12

Family

ID=22486056

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/040199 Ceased WO2000077236A2 (en) 1999-06-15 2000-06-14 Methods for enhancing the production of cytokines in cell cultur e

Country Status (7)

Country Link
EP (1) EP1255848A2 (en)
JP (1) JP2003509012A (en)
CN (1) CN1399681A (en)
AU (1) AU6403700A (en)
CA (1) CA2376487A1 (en)
HK (1) HK1048650A1 (en)
WO (1) WO2000077236A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031859A1 (en) * 1999-09-08 2001-10-18 Lau Allan S. High level cytokine production with enhanced cell viability
JP2004529851A (en) * 2000-09-12 2004-09-30 ジーントロール バイオセラピューティクス， インコーポレイテッド Composition containing a mixture of human cytokines and method for producing the same
AU2001290855A1 (en) 2000-09-14 2002-03-26 Genetrol Biotherapeutics, Inc. Method and cell composition for screening compounds for anti-inflammatory activity
WO2002062837A2 (en) * 2000-12-19 2002-08-15 Genetrol Biotherapeutics, Inc. Cells with enhanced pkr expression for increasing cytokine production
EP1844069A4 (en) * 2005-01-28 2009-05-20 Apollo Life Sciences Ltd Molecules and chimeric molecules thereof
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
JP6612227B2 (en) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド Cell growth in bioreactors
EP3122866B1 (en) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passive replacement of media
US20160090569A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled Feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
JP6916884B2 (en) * 2017-01-02 2021-08-11 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ B cell culture method
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
JP7393945B2 (en) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド cell proliferation
WO2022204315A1 (en) 2021-03-23 2022-09-29 Terumo Bct, Inc. Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017043A1 (en) * 1992-02-28 1993-09-02 Brigham & Women's Hospital Methods and compounds for prevention of graft rejection
WO1997008324A1 (en) * 1995-08-22 1997-03-06 The Regents Of The University Of California Methods for enhancing the production of interferon in cell culture
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
WO1993017043A1 (en) * 1992-02-28 1993-09-02 Brigham & Women's Hospital Methods and compounds for prevention of graft rejection
WO1997008324A1 (en) * 1995-08-22 1997-03-06 The Regents Of The University Of California Methods for enhancing the production of interferon in cell culture

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRETON J J ET AL: "THE NATURAL PRODUCT HYMENIALDISINE INHIBITS INTERLEUKIN-8 PRODUCTION IN U937 CELLS BY INHIBITION OF NUCLEAR FACTOR-KAPPA B", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,US,AMERICAN SOCIETY FOR PHARMACOLOGY AND, vol. 282, no. 1, 1997, pages 459 - 466, XP002910635, ISSN: 0022-3565 *
HARANT H ET AL: "1ALPHA,25-DIHYDROXYVITAMIN D3 AND A VARIETY OF ITS NATURAL METABOLITES TRANSCRIPTIONALLY REPRESS NUCLEAR-FACTOR-KB-MEDIATED INTERLEUKIN-8 GENE EXPRESSION", EUROPEAN JOURNAL OF BIOCHEMISTRY,DE,BERLIN, vol. 282, no. 1, November 1997 (1997-11-01), pages 63 - 71, XP002915093, ISSN: 0014-2956 *
KUMAR ASEEM ET AL: "Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa-B by phosphorylating I-kappa-B.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 91, no. 14, 1994, 1994, pages 6288 - 6292, XP002170325, ISSN: 0027-8424 *
LIBERMANN T A ET AL: "ACTIVATION OF INTERLEUKIN-6 GENE EXPRESSION THROUGH THE NF-KAPPA-B TRANSCRIPTION FACTOR", MOLECULAR AND CELLULAR BIOLOGY, vol. 10, no. 5, 1990, pages 2327 - 2334, XP002160675, ISSN: 0270-7306 *
LINDHOLM P F ET AL: "EXTRACELLULAR TAX-1 PROTEIN STIMULATES TUMOR NECROSIS FACTOR-BETA AND IMMUNOGLOBULIN KAPPA LIGHT CHAIN EXPRESSION IN LYMPHOID CELLS", JOURNAL OF VIROLOGY, vol. 66, no. 3, 1992, pages 1294 - 1302, XP000993234, ISSN: 0022-538X *

Also Published As

Publication number Publication date
CN1399681A (en) 2003-02-26
WO2000077236A2 (en) 2000-12-21
HK1048650A1 (en) 2003-04-11
CA2376487A1 (en) 2000-12-21
EP1255848A2 (en) 2002-11-13
AU6403700A (en) 2001-01-02
JP2003509012A (en) 2003-03-11

Similar Documents

Publication Publication Date Title
WO2000077236A3 (en) Methods for enhancing the production of cytokines in cell cultur e
WO2003014336A1 (en) Process for preparing hematopoietic stem cells
WO2003010302A1 (en) Cultured cell construct containing spheroids of cultured animal cells and utilization thereof
WO2001023592A3 (en) Methods for making recombinant proteins using apoptosis inhibitors
AU2001236042A1 (en) Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
AU2002309510A1 (en) Method for modifying plant biomass
MXPA02012324A (en) Methods and compositions for simultaneous saccharification and fermentation.
NZ514025A (en) Compositions and methods for the modification of gene transcription
EP0945515A3 (en) Production of proteins using homologous recombination
ZA942719B (en) Expression of heterologous genes
AU1720400A (en) Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
AU2001286202A1 (en) Method of culturing mesenchymal stem cells
AU2003255309A1 (en) Method and device for culturing cells
BR0012712B1 (en) l-amino acid production methods by increasing the cellular nadph.
AU4017501A (en) Cell culture spinner flasks
MXPA03005548A (en) Methods for the production of multimeric proteins, and related compositions.
WO2000056905A3 (en) Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
WO2000070022A3 (en) Ex vivo expansion of mammalian hematopoietic stem cells
WO2000046375A3 (en) Methods for producing polypeptides in fungal cells
ATE366803T1 (en) HIGH CYTOKINE PRODUCTION WITH IMPROVED CELL VIABILITY
AU2001281018A1 (en) Enhanced 2-keto-l-gulonic acid production
EP1229111A3 (en) Cultured cells of Ficus stipulata thunb. (= Ficus thunbergii) and a method for culturing tissues of the Ficus stipulata by using said cultured cells
WO2006113147A3 (en) Ascorbic acid production from d-glucose in yeast
AU2003206926A1 (en) Cultivation method for micro-organisms and bioreactor
WO2000046378A3 (en) Method of improving the primary energy metabolism of mammalian cell lines

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00809023.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 64037/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2001 503677

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2376487

Country of ref document: CA

Ref document number: 2376487

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2000951042

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2000951042

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000951042

Country of ref document: EP